Mariuca Vasa-Nicotera, MD

Original Contribution

Eptifibatide-Eluting Stent as an Antiproliferative and Antithrombotic Agent: In Vitro Evaluation

08/01/2008

Anthony H. Gershlick , MD, FRCP, MB, BS , BSc;

Coronary stent placement is the most commonly employed technique for percutaneous treatment of atherosclerotic heart disease. It accounts for about 75% of the procedures performed worldwide.1 In comparison to conventional balloon angioplasty,...

Coronary stent placement is the...

08/01/2008

Journal of Invasive Cardiology

Original Contribution

Hemodynamic Outcome and Valve Durability Beyond Five Years After Transcatheter Aortic Valve Replacement

02/29/2020

Eileen Hofmann , MD;

Roberta De Rosa , MD;

Silvia Mas-Peiro , MD, MSc;

Philipp Christian Seppelt , MD;

Stephan Fichlscherer , MD;

Mariuca Vasa-Nicotera , MD;

Thomas Walther , MD, PhD;

Andreas M. Zeiher , MD;

Marie-Isabel Murray , MD;

The aim of this study was to evaluate hemodynamic outcome, structural valve deterioration, and bioprosthetic valve failure beyond 5 years after transcatheter aortic valve replacement (TAVR). Demographic, procedural, and outcome data were...

The aim of this study was to...

02/29/2020

Journal of Invasive Cardiology

Case Study

A Direct Comparison of Self-Expandable Portico Versus Balloon-Expandable Sapien 3 Devices for Transcatheter Aortic Valve Replacement: A Case-Matched Cohort Study

06/28/2019

Gina-Lisa Mohr , MD;

Nestoras Papadopoulos , MD;

Stephan Fichtlscherer , MD;

Andreas M. Zeiher , MD;

Silvia Mas-Peiro , MD, MSc;

Mariuca Vasa-Nicotera , MD;

Thomas Walther , MD, PhD;

Helge Weiler , MD;

This is the first study to directly compare the Portico valve with the Sapien 3 valve; we compared 104 Portico valves and 73 Sapien 3 valves at a high-volume center in a real-world setting.

This is the first study to...

06/28/2019

Journal of Invasive Cardiology